Mas texto en la ventana.
BioSpain 2014 strengthens its international presence and includes ‘Open Innovation’ model
Through the ‘Open Innovation’ model BioSpain has ceded control over some of its content to high-profile partners, leading to the organisation of ten sessions by scientific societies, and the Stakeholder Forum.
Madrid, 12th May 2014. BioSpain 2014 (www.biospain2014.org), the seventh International Biotechnology Conference, a biennial event that will take place from the 24th to the 26th of September in the Palacio de Congresos y Exposiciones de Galicia (Galician Conference Centre), in Santiago de Compostela (A Coruña), which is organised by the Spanish Bioindustry Association (ASEBIO) and on this edition, also by the Autonomous Government of Galicia, the University of santiago de Compostela, the University of Vigo and Santiago City Council, brings us important new features, while this year BioSpain has strengthened its international presence and brought in the ‘Open Innovation’ model, which is starting to play a dominant role across all economic sectors. This new element was announced during the official presentation for the fair, which was attended by Ms Rocío Mosquera, Galician Minister for Health; Ms Regina Revilla, President of ASEBIO; and Mr Jorge Barrero, Deputy to the President of ASEBIO.
As of today, according to the data provided by the organizers, the participation of 350 companies and institutions from 20 countries has already been confirmed, with over 100 exhibitors, 27 sponsors, 23 collaborating entities, 10 of which are scientific societies, and around 100 international companies. This September we are expecting to attract 2,000 participants, 10% more than in 2012, exceeding the benchmark of 800 companies and institutions from 40 countries set that year.
Through the incorporation in this edition of the ‘Open Innovation’ model, ASEBIO has passed control over some of the content to high profile partners, including the 10 science sessions organised by scientific and medical societies and the International Seminar on Personalised Medicine organised by Roche for this year’s fair.
Similarly, as pointed out by Regina Revilla, President of ASEBIO, “the Stakeholder Forum has been designed with the same ‘open’ spirit, offering content aimed at and created by ‘non-professionals’: patients, consumers and jobseekers who will have their own fair within the event.” It will be the first time that some of this content is broadcast - via streaming - allowing debates to take place on social networking sites before, during and after the session.
BioSpain, which in its 7th edition coincides with the the Year for Biotechnology in Spain and ASEBIO’s 15th anniversary, is the main biotechnology event in Spain and one of the most important on the international stage in terms of attendance numbers (726 companies and 1,850 visitors in 2012) and the number of business meetings (2,775 in 2012). In 2012 BioSpain consolidated its position as one of the leading international biotechnology conferences,
becoming the fifth biggest globally in terms of partnering meetings and participating companies; and the biggest country-based event in Europe.
In regards to international presence it is expected that just at the investors forum there will be 40 specialised funds from all around the world. Furthermore, according to data provided by the organisers, leading figures from alliances involving several pharmaceutical companies and a large number of biotechnology firms, as well as leading researchers from multiple disciplines, have already confirmed their attendance. “Our objective is to reach the 30% mark for international visiting public and, in fact, English is again the official language. BioSpain 2014 has also incorporated a new module, ‘Biolatam Showcase,’ providing continuity between editions of the Latin American version of the event, it is designed to be a ‘display window’ for that part of the world - here in Europe; we are also trying to bolster the presence of companies from leading markets such as that of the US and the UK, without neglecting important emerging economies such as Russia and Turkey,” explained the President of ASEBIO.
In that regard she also confirmed that “within two weeks an ASEBIO delegation will travel to South Korea to encourage the presence of Asian companies in BioSpain, which are just as important.”
A meeting point for all the innovative healthcare community
As well as bolstering its international presence and adopting the concept of ‘open innovation,’ the 7th edition of BioSpain brings other important innovations. One is that this year’s fair has been conceived as a meeting point for the innovative healthcare community. That is to say, this event will not only be aimed at the health, pharmaceutical or healthcare products biotech industries, but also at biomedical research centres and, particularly, at hospitals which are committed to technology transfer and research. “This is a concept which ASEBIO categorises as an Entrepreneurial Hospital and I want express my support for the courageous policy which Galicia is carrying out in this area,” stated Regina Revilla.
Rocío Mosquera, Galician Minister for Health explained “we wanted to present a candidacy on a par with a country, supported by the Government of Galicia, coordinated by the Galician Ministry of Health and participated in by other Ministries of the Government of Galicia, such as Economy and Industry, Rural Affairs and the Sea, Work and Social Affairs and the Galician Tourism Agency; it also has the support of the Santiago de Compostela City Council and the Universities of Santiago de Compostela and Vigo. We are convinced that our confidence and support for the biotechnology sector, a forward-looking and innovative sector, will contribute towards the consolidation of Spain’s assets in the field of biomedical research.”
Finally, a notable recent development and fourth pillar for this edition of BioSpain is the diversification towards other biotechnology user markets. “That is the case of the chemicals, food and cosmetics industries, which we are also reaching out to, as well as new business niches such as marine and forest biotechnology and what is referred to as the bioeconomy, which Europe is putting forward as a sustainable alternative to the fossil fuel economy and which will allow us to produce a variety of materials and products (fuels, plastics, lubricants etc) using vegetable waste and industrial crops as raw materials,” assured the President of ASEBIO.
The official sponsors for BioSpain 2014 are Bioibérica, Merck, MSD, Zeltia Group, Roche Institute and CLAMBER (Castilla La Mancha Bioeconomy Region).
For further information:
Head of Communications for BioSpain 2014 and ASEBIO
landline. + 34 912109374/10
mobile: + 34 663 117 293
BioSpain 2014 Press Office: BERBÉS ASOCIADOS
Jorge Sánchez / Irene Fernández
landline: 91 563 23 00 / 678 544 149 / 661 67 82 83
Twitter: @BioSpain2014 (https://twitter.com/BioSpain2014)
Linkedin Group: ‘BioSpain 2014’
Inversores de 11 países analizan 30 proyectos de biotecnología españolaRead more
El top ten de fondos de inversión asistentes a Biospain 2016 gestionan activos valorados en más de 5.000 millones de eurosRead more
The ten biggest funds at Biospain 2016 manage assets of over 5 billion eurosRead more
Los pacientes piden en Biospain 2016 una participación activa en las políticas de salud y en el sistema sanitarioRead more
El descubrimiento del ‘GPS humano’ abre una nueva era en la ingeniería genéticaRead more
La biotecnología agrícola, clave para afrontar el problema de la superpoblación y el cambio climáticoRead more
Biospain 2016 ya cuenta con una APP gratuita para seguir el eventoRead more
US expects to increase its presence in Biospain 2016Read more
Bilbao will host BioSpain 2016Read more
BioSpain 2016 will be the hub of Biotechnology in AutummRead more
Bilbao acogerá BioSpain 2016Read more
EE.UU. prevé incrementar su presencia en Biospain 2016Read more
BioSpain 2016 selecciona a cuatro sociedades científicasRead more
El 82% de los asistentes a Biospain identificaron oportunidades reales de negocioRead more
82% of participants at Biospain identified real business opportunitiesRead more
La inmunoterapia se postula como uno de los pilares terapéuticos del cáncerRead more
La bioeconomía se consolida como una herramienta clave para afrontar los retos futuros del planetaRead more
BioSpain 2014 increases its internationalisation by 43% compared to the previous editionRead more
Participantes en Biospain de 16 países llegarán a la feria por el camino #XacobioRead more
BioSpain 2014 amplía su Foro de Inversión con más perfiles de inversores y más empresas participantesRead more
BioSpain 2014 expands its Investment Forum through wider range of investor profiles and more participating companiesRead more
BioSpain 2014 refuerza su presencia internacional e incorpora el modelo de “Innovación en abierto”Read more